ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

When Should Therapeutic Anticoagulation Be Restarted Following Major Head and Neck Surgery?

by Ashok R. Jethwa, MD, and Samir S. Khariwala, MD, MS • August 7, 2018

  • Tweet
  • Email
Print-Friendly Version

TRIO Best PracticeTRIO Best Practice articles are brief, structured reviews designed to provide the busy clinician with a handy outline and reference for day-to-day clinical decision making. The ENTtoday summaries below include the Background and Best Practice sections of the original article. To view the complete Laryngoscope articles free of charge, visit Laryngoscope.

You Might Also Like

  • What Is the Preferred Perioperative Antibiotic Following Major Head and Neck Surgery?
  • Anticoagulation Not Necessary to Prevent DVT After Head-Neck Surgery
  • Chemoprophylaxis for VTE following Head and Neck Surgery
  • Endoscopic Technology Brings Major Changes to Head and Neck Surgery
Explore This Issue
August 2018

Background

Each year in the United States, approximately 250,000 patients are faced with a challenging situation regarding the periprocedural management of their anticoagulation and antiplatelet medications. The most common of these medications include aspirin, warfarin, and clopidogrel. However, several new oral anticoagulants including rivaroxaban, apixaban, and dabigatran, among others, have emerged. Head and neck cancer surgeries are considered high-risk bleeding procedures, and thus, the decision to resume these medications following surgery must be made thoughtfully. Several studies have demonstrated an increased risk of venous and arterial thromboembolism during lapses in these medications. Conversely, earlier resumption of these medications can increase the risk of postoperative hemorrhage and hematoma. The development of these complications in a patient who has undergone major head and neck surgery can be a significant setback and may result in prolonged hospitalization, airway distress, wound complications, and need for transfusions. Currently, clarity is lacking among head and neck surgeons regarding the optimal timing of restarting anticoagulation following head and neck surgery. Thus, we sought to review the existing literature addressing periprocedural resumption of anticoagulant/antiplatelet medications.

Best Practice

Head and neck surgeries are considered high-risk bleeding procedures. It is recommended that warfarin be resumed 12 to 24 hours after surgery; rivaroxaban, apixaban, and dabigatran can be resumed two to three days postoperatively; aspirin and clopidogrel can be resumed 24 hours after surgery (Laryngoscope. 2018;128:1025–1026).

*Can consider starting a reduced dose immediately after surgery in patients at high risk of thromboembolism.

(click for larger image) Postoperative Resumption of Antiplatelet and Anticoagulant Medications.
*Can consider starting a reduced dose immediately after surgery in patients at high risk of thromboembolism.

Filed Under: Head and Neck, TRIO Best Practices Tagged With: head and neck surgery, therapeutic anticoagulation, treatmentIssue: August 2018

You Might Also Like:

  • What Is the Preferred Perioperative Antibiotic Following Major Head and Neck Surgery?
  • Anticoagulation Not Necessary to Prevent DVT After Head-Neck Surgery
  • Chemoprophylaxis for VTE following Head and Neck Surgery
  • Endoscopic Technology Brings Major Changes to Head and Neck Surgery

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Weaning Patients Off of PPIs
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Did You Receive COVID-19 Relief? Here Are Reporting Considerations for 2021
    • Otolaryngology Experts Share Best Practices in Five Areas
    • How Climate Change May Be Affecting Sleep Patterns for Adults and Children
    • Laryngologists Discuss Tough Tracheostomy Choices During COVID-19 Era
    • Head and Neck Cancer: Experts Discuss How to Improve Surgery Quality and Value

Polls

Did you receive funding from the CARES Act or Paycheck Protection Program?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.